Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 26, 2021

SELL
$3.8 - $4.56 $138,320 - $165,984
-36,400 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$4.87 - $17.29 $177,268 - $629,356
36,400 New
36,400 $220,000
Q4 2018

Jan 23, 2019

SELL
$19.05 - $36.45 $152,400 - $291,600
-8,000 Closed
0 $0
Q3 2018

Oct 19, 2018

SELL
$34.41 - $44.23 $268,398 - $344,994
-7,800 Reduced 49.37%
8,000 $297,000
Q2 2018

Aug 06, 2018

BUY
$39.21 - $50.29 $54,894 - $70,406
1,400 Added 9.72%
15,800 $619,000
Q1 2018

Apr 20, 2018

SELL
$41.7 - $64.16 $187,650 - $288,720
-4,500 Reduced 23.81%
14,400 $707,000
Q4 2017

Jan 23, 2018

SELL
$28.58 - $49.91 $108,604 - $189,658
-3,800 Reduced 16.74%
18,900 $855,000
Q3 2017

Oct 23, 2017

BUY
$23.08 - $34.92 $523,915 - $792,684
22,700
22,700 $792,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $723M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.